Melatonin’s Effect on the Efficacy of Desmopressin in the Treatment of Enuresis

다국어 초록 (Multilingual Abstract)

Purpose: This study aims to evaluate and compare the efficacy of exogenous melatonin associated with desmopressin (dDAVP) and dietary recommendations.
Methods: A total of 189 patients were enrolled from the Service of Pediatrics, Campus Bio-Medico University Hospital of Rome, from January 2013 to June 2015. Of the 189 original patients, 153 children, aged between 5 and 14 years (mean age, 8.7 years) were included in the study. After clinical evaluation and a 3-month period of observation without treatment, children were assigned to receive treatment in one of 3 groups: group 1, dDAVP at a dose of 120 mcg a day (Minirin); group 2, dDAVP at a dose of 120 mcg and dietary recommendations; or group 3, dDAVP at a dose of 120 mcg, dietary recommendations, and melatonin at a dose of 1 mg a day (Melamil plus). Each patient was treated for 3 months.
Results: After the 3 months of therapy, a desiderable response was achieved in 30 of 51 patients (58.82%) treated with dDAVP, 35 of 53 patients (66.04%) treated with dDAVP and dietary recommendations, and 35 of 49 patients (71.43%) treated with dDAVP, dietary recommendations, and melatonin.
Conclusions: Although not statistically significant, the results show that the association between dDAVP treatment with dietary recommendations and melatonin could be considered a safe and effective treatment of NE. Considering that the statistically insignificant results might be due to the small sample size, the study will be continued to increase the number of subjects.

참고문헌 (Reference)

1 Bakker E, "Voiding habits and wetting in a population of 4,332 Belgian schoolchildren aged between 10 and 14 years" 36 : 354-362, 2002

2 Skene DJ, "Use of melatonin in the treatment of phase shift and sleep disorders" 467 : 79-84, 1999

3 Austin PF, "The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children’s Continence Society" 191 : 1863-1865, 2014

4 Nevéus T, "The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society" 176 : 314-324, 2006

5 van Gool JD, "Subtypes in monosymptomatic nocturnal enuresis. II" 202 : 8-11, 1999

6 Caldwell PH, "Simple behavioural interventions for nocturnal enuresis in children" (7) : CD003637-, 2013

7 Theunis M, "Self-image and performance in children with nocturnal enuresis" 41 : 660-667, 2002

8 Robson WL, "Primary and secondary nocturnal enuresis: similarities in presentation" 115 : 956-959, 2005

9 Kennaway DJ, "Potential safety issues in the use of the hormone melatonin in paediatrics" 51 : 584-589, 2015

10 Ferrara P, "Possible impact of comorbid conditions on the persistence of nocturnal enuresis: results of a long-term follow-up study" 11 : 1777-1782, 2014

11 Ferrara P, "Oral desmopressin lyophilisate (MELT) for monosymptomatic enuresis: structured versus abrupt withdrawal" 10 : 52-55, 2014

12 Hardeland R, "Melatonin: a pleiotropic, orchestrating regulator molecule" 93 : 350-384, 2011

13 Merks BT, "Melatonin treatment in children with therapy-resistant monosymptomatic nocturnal enuresis" 8 : 416-420, 2012

14 Szeinberg A, "Melatonin treatment in adolescents with delayed sleep phase syndrome" 45 : 809-818, 2006

15 Ardura-Fernandez J, "Melatonin rhythm in children with enuresis" 99 : 413-415, 2007

16 Kennaway DJ, "Melatonin and circadian rhythms" 2 : 199-209, 2002

17 Deshpande AV, "Medical management of nocturnal enuresis" 14 : 71-77, 2012

18 Guzelsoy M, "Impact of urinary incontinence on quality of life among residents living in Turkey" 11 : 1447-1451, 2014

19 Ferrara P, "Homotoxicological remedies versus desmopressin versus placebo in the treatment of enuresis: a randomised, doubleblind, controlled trial" 23 : 269-274, 2008

20 Fergusson DM, "Factors related to the age of attainment of nocturnal bladder control: an 8-year longitudinal study" 78 : 884-890, 1986

21 Neveus T, "Enuresis--background and treatment" (206) : 1-44, 2000

22 Shadpour P, "Enuresis persisting into adulthood" 3 : 117-129, 2006

23 American Psychiatric Association, "Diagnostic and statistical manual of mental disorders, 5th ed (DSM-V)" American Psychiatric Publishing 2013

24 Ferrara P, "Combined dietary recommendations, desmopressin, and behavioral interventions may be effective first-line treatment in resolution of enuresis" 12 : 2228-2232, 2015

25 Robson WL, "Clinical practice: evaluation and management of enuresis" 360 : 1429-1436, 2009

26 Yeung CK, "Characteristics of primary nocturnal enuresis in adults: an epidemiological study" 93 : 341-345, 2004

27 Howe AC, "Behavioral management of toilet training, enuresis, and encopresis" 39 : 413-432, 1992

28 Butler RJ, "Annotation: night wetting in children: psychological aspects" 39 : 453-463, 1998

29 Rogers J, "An overview of the management of nocturnal enuresis in children" 12 : 898-903, 2003

30 Chiozza ML, "An Italian epidemiological multicentre study of nocturnal enuresis" 81 (81): 86-89, 1998

31 Rittig S, "Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis" 256 (256): F664-F671, 1989